MENU
+Compare
ALMS
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$11.40
Change
-$0.05 (-0.44%)
Capitalization
1.19B

ALMS Alumis Inc. Forecast, Technical & Fundamental Analysis

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders... Show more

ALMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ALMS with price predictions
Dec 24, 2025

ALMS sees MACD Histogram crosses below signal line

ALMS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 19, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 14 instances where the indicator turned negative. In of the 14 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ALMS moved out of overbought territory on December 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 13 cases where ALMS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on December 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALMS as a result. In of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALMS broke above its upper Bollinger Band on December 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALMS advanced for three days, in of 74 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 24 cases where ALMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.093) is normal, around the industry mean (26.541). P/E Ratio (0.166) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (37.313) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ALMS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LBRIX29.230.09
+0.31%
ClearBridge Dividend Strategy FI
HNVRX43.710.12
+0.28%
Harbor Small Cap Value Retirement
MIPTX22.180.04
+0.18%
Matthews Pacific Tiger Instl
LSMNX14.800.02
+0.14%
Loomis Sayles Small/Mid Cap Growth N
YOVLX16.18N/A
N/A
Yorktown Small-Cap L

ALMS and Stocks

Correlation & Price change

A.I.dvisor tells us that ALMS and KRRO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and KRRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
-0.44%
KRRO - ALMS
26%
Poorly correlated
+0.12%
ZBIO - ALMS
23%
Poorly correlated
+0.84%
XENE - ALMS
22%
Poorly correlated
+1.06%
GERN - ALMS
22%
Poorly correlated
+5.26%
RLYB - ALMS
22%
Poorly correlated
-3.13%
More